You cannot register for this webinar

This webinar has ended. Thank you for your interest.

Topic

RedChip Investor Group Call with BioVie Inc. (NASDAQ: BIVI)

Date & Time

Selected Sessions:

Jul 21, 2022 08:15 PM

Description

BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI.